Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120252) titled 'Development of a Digital Molecular Diagnostic Kit for Pediatric Epilepsy Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry' on March 11.
Study Type: Diagnostic test
Study Design:
Diagnostic test: case-control
Primary Sponsor: Capital Children's Medical Center, Capital Medical University
Condition:
Epilepsy
Intervention:
Gold Standard:According to the latest standards of the International League Against Epilepsy (ILAE) in 2017, combined with a detailed clinical history and the results of video electroencephalogram (vEEG) examination, epilepsy was diagnosed for the first time.
Recrui...